Harmony Biosciences Holdings (HRMY) Operating Margin Growth (1y) (2021 - 2026)

Harmony Biosciences Holdings (HRMY) Operating Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Harmony Biosciences Holdings 2.07 Bn 1.55 Bn 170.88 Mn -1,313.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,313.00
Dec 31, 2025 -1,187.00
Sep 30, 2025 -582.00
Jun 30, 2025 1,167.00
Mar 31, 2025 -321.00
Dec 31, 2024 382.00
Sep 30, 2024 -708.00
Jun 30, 2024 -2,259.00
Mar 31, 2024 -28.00
Dec 31, 2023 -1,324.00
Sep 30, 2023 3,010.00
Jun 30, 2023 400.00
Mar 31, 2023 163.00
Dec 31, 2022 572.00
Sep 30, 2022 -1,592.00
Jun 30, 2022 -64.00
Mar 31, 2022 795.00
Dec 31, 2021 1,761.00
Sep 30, 2021 332.00
Jun 30, 2021 1,235.00